Leading the Way in Life Science Technologies

GEN Exclusives

More »

GEN News Highlights

More »
Mar 31, 2010

Veritas to Supply International Stem Cell’s Products in Japan

  • International Stem Cell (ISCO) granted Veritas distribution rights for its human cell culture products throughout Japan. The deal was signed through International Stem Cell’s wholly owned subsidiary, Lifeline Cell Technology.

    Lifeline, located in Maryland and California, specializes in the development, manufacture, and distribution of products to culture human cells, including products to culture primary human cells and human stem cells. This agreement marks the first step in Lifeline’s plan to meet requests from Japan, Korea, and India.

    Lifeline points out that its products are used for clinical applications and in academic, government, and pharmaceutical research laboratories. ISCO has also developed human parthenogenetic stem cell lines (hpSC). The firm believes that hpSCs could potentially minimize the rejection of transplanted cells by a patient’s immune system as well as avoid the ethical issues that are stifling research with embryonic stem cells.

Related content

Be sure to take the GEN Poll

Scientifically Studying Ecstasy

MDMA (commonly known as the empathogen “ecstasy”) is classified as a Schedule 1 drug, which is reserved for compounds with no accepted medical use and a high abuse potential. Two researchers from Stanford, however, call for a rigorous scientific exploration of MDMA's effects to identify precisely how the drug works, the data from which could be used to develop therapeutic compounds.

Do you agree that ecstasy should be studied for its potential therapeutic benefits?

More »